Albemarle (ALB) Projected to Post Earnings on Wednesday

Albemarle (NYSE:ALB) is anticipated to issue its Q2 2025 quarterly earnings data after the market closes on Wednesday, July 30th. Analysts expect the company to announce earnings of ($0.76) per share and revenue of $1.23 billion for the quarter. Albemarle has set its FY 2025 guidance at EPS.

Albemarle (NYSE:ALB) last announced its quarterly earnings results on Wednesday, April 30th. The specialty chemicals company reported ($0.18) EPS for the quarter, beating the consensus estimate of ($0.62) by $0.44. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.18 billion. Albemarle had a negative net margin of 22.39% and a negative return on equity of 1.92%. The firm’s revenue was down 20.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.26 earnings per share. On average, analysts expect Albemarle to post $0 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Albemarle Stock Performance

Shares of ALB opened at $83.84 on Monday. The company has a current ratio of 2.11, a quick ratio of 1.26 and a debt-to-equity ratio of 0.39. The firm has a market cap of $9.87 billion, a PE ratio of -7.54 and a beta of 1.63. The company’s 50 day simple moving average is $64.81 and its 200-day simple moving average is $69.65. Albemarle has a 12-month low of $49.43 and a 12-month high of $113.91.

Albemarle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, September 12th will be given a dividend of $0.405 per share. The ex-dividend date of this dividend is Friday, September 12th. This represents a $1.62 dividend on an annualized basis and a dividend yield of 1.93%. Albemarle’s dividend payout ratio (DPR) is presently -14.57%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on ALB shares. UBS Group set a $57.00 price objective on shares of Albemarle and gave the company a “sell” rating in a research report on Friday, July 11th. Piper Sandler set a $68.00 price target on Albemarle and gave the stock an “underweight” rating in a research note on Wednesday, May 14th. Wall Street Zen raised shares of Albemarle to a “sell” rating in a research note on Monday, May 5th. Wells Fargo & Company boosted their target price on shares of Albemarle from $60.00 to $75.00 and gave the company an “equal weight” rating in a research note on Monday, July 14th. Finally, Citigroup cut their target price on shares of Albemarle from $85.00 to $64.00 and set a “neutral” rating for the company in a research note on Tuesday, April 15th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $91.00.

Hedge Funds Weigh In On Albemarle

Hedge funds and other institutional investors have recently bought and sold shares of the stock. United Services Automobile Association acquired a new position in shares of Albemarle in the 1st quarter valued at approximately $208,000. AQR Capital Management LLC raised its position in shares of Albemarle by 25.5% in the 1st quarter. AQR Capital Management LLC now owns 3,223 shares of the specialty chemicals company’s stock valued at $229,000 after purchasing an additional 654 shares in the last quarter. Integrated Wealth Concepts LLC raised its position in shares of Albemarle by 26.2% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,798 shares of the specialty chemicals company’s stock valued at $346,000 after purchasing an additional 996 shares in the last quarter. Finally, Empowered Funds LLC acquired a new position in shares of Albemarle in the 1st quarter valued at approximately $411,000. 92.87% of the stock is owned by institutional investors and hedge funds.

About Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.